DarioHealth (DRIO) Common Equity (2012 - 2026)

DarioHealth's Common Equity history runs 15 years deep, the most recent figure standing at $62.4 million for Q1 2026.

• Quarterly Common Equity fell 15.36% year-over-year to $62.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $62.4 million (down 15.36% YoY) and the FY2025 annual result came in at $67.9 million, down 5.69% from the prior year.
• Common Equity was $62.4 million for Q1 2026 at DarioHealth, down from $67.9 million in the prior quarter.
• Across five years, Common Equity topped out at $114.2 million in Q1 2022 and bottomed at $58.1 million in Q4 2023.
• A 5-year average of $75.2 million and a median of $72.0 million in 2023 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2023 — Common Equity tumbled 36.92% — and 2025, when it increased 28.07%.
• DarioHealth's Common Equity stood at $80.0 million in 2022, then slipped by 27.32% to $58.1 million in 2023, then climbed by 23.86% to $72.0 million in 2024, then retreated by 5.69% to $67.9 million in 2025, then fell by 8.16% to $62.4 million in 2026.
• Business Quant data shows DRIO's Common Equity at $62.4 million in Q1 2026, $67.9 million in Q4 2025, and $74.9 million in Q3 2025.